Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Scarpato L."'
Autor:
Monfrecola G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II., Fornaro L; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II., Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Scarpato L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Costa C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Martora F; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II., Marasca C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 Sep; Vol. 37 (9), pp. e1123-e1124. Date of Electronic Publication: 2023 Jun 20.
Autor:
Martora F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II., Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Scalvenzi M; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II., Palla M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Costa C; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II., D'Andrea M; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Di Trolio R; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Scarpato L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale., Marasca C; Dermatology Unit, Medical Department, 'Antonio Cardarelli' National Hospital, Naples, Italy.
Publikováno v:
Clinical and experimental dermatology [Clin Exp Dermatol] 2024 Jan 25; Vol. 49 (2), pp. 183-185.
Autor:
Martora F; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy., Ascierto P; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Costa C; Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy., D'Andrea M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Di Trolio R; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Naples, Italy., Marasca C; Dermatology Unit, Medical Department, 'Antonio Cardarelli' National Hospital of Naples, Italy.
Publikováno v:
Clinical and experimental dermatology [Clin Exp Dermatol] 2023 Nov 16; Vol. 48 (12), pp. 1373-1374.
Autor:
Monfrecola G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Fornaro L; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Ascierto PA; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Scarpato L; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Anniciello AM; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy., Fabbrocini G; Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy., Marasca C; Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2023 Sep; Vol. 37 (9), pp. e1117-e1118. Date of Electronic Publication: 2023 Mar 23.
Autor:
Mallardo D; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Simeone E; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Festino L; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Tuffanelli M; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vanella V; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Trojaniello C; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vitale MG; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Ottaviano M; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Capone M; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Madonna G; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Sparano F; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Cioli E; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Scarpato L; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Palla M; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Di Trolio R; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Meinardi P; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Caracò C; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Ferrara G; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Muto P; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Cavalcanti E; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Ascierto PA; Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy. p.ascierto@istitutotumori.na.it.
Publikováno v:
Journal of translational medicine [J Transl Med] 2023 Feb 23; Vol. 21 (1), pp. 140. Date of Electronic Publication: 2023 Feb 23.
Autor:
Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Paone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., De Cristofaro T; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Borzillo V; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Cortellini A; Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W120HS, UK., Sparano F; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Fiore F; Interventional Radiology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Caracò C; Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Maiolino P; Hospital Pharmacy, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Petrillo A; Radiology Division, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Cavalcanti E; Division of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Lastoria S; Nuclear Medicine Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Muto P; Radiation Oncology Unit, Istituto Nazionale Tumori - IRCCS -Fondazione 'G. Pascale', Naples, Italy., Budillon A; Experimental Pharmacology Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy., Warren S; NanoString Technologies, Seattle, WA, USA., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori - IRCCS - Fondazione 'G. Pascale', Naples, Italy. p.ascierto@istitutotumori.na.it.
Publikováno v:
Journal of translational medicine [J Transl Med] 2022 Sep 30; Vol. 20 (1), pp. 436. Date of Electronic Publication: 2022 Sep 30.
Autor:
Granata V; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy. v.granata@istitutotumori.na.it., Simonetti I; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy., Fusco R; Medical Oncology Division, Igea SpA, Naples, Italy., Setola SV; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy., Izzo F; Hepatobiliary Surgical Oncology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia',, Via Mariano Semmola, Naples, Italy., Scarpato L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Vanella V; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Festino L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Simeone E; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy., Petrillo A; Radiology Division, 'Istituto Nazionale Tumori - IRCCS - Fondazione G. Pascale, Naples, Italia', Via Mariano Semmola, Naples, Italy.
Publikováno v:
La Radiologia medica [Radiol Med] 2022 Aug; Vol. 127 (8), pp. 899-911. Date of Electronic Publication: 2022 Jul 14.
Autor:
Palla M; Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy., Di Trolio R; Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy paolo.ascierto@gmail.com.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jun; Vol. 10 (6).
Autor:
Scarpato L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Festino L; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Vanella V; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Madonna G; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Mastroianni M; Department of Otolaryngology Surgery and Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Palla M; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Ascierto PA; Department of Skin Cancers, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Publikováno v:
Expert opinion on drug safety [Expert Opin Drug Saf] 2022 Mar; Vol. 21 (3), pp. 385-395. Date of Electronic Publication: 2021 Nov 02.
Autor:
Madonna G; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Masucci GV; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Capone M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Grimaldi AM; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Vanella V; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Festino L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Palla M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Scarpato L; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Tuffanelli M; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., D'angelo G; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy., Villabona L; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden., Krakowski I; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden.; Theme Inflammation, Karolinska University Hospital, 171 76 Stockholm, Sweden., Eriksson H; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Simao F; Genevia Technologies OY, 33100 Tampere, Finland., Lewensohn R; Theme Cancer, Karolinska University Hospital, 171 76 Stockholm, Sweden.; Department of Oncology and Pathology, Karolinska Institutet, 171 64 Stockholm, Sweden., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, 80131 Napoli, Italy.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Aug 19; Vol. 13 (16). Date of Electronic Publication: 2021 Aug 19.